You have a ligand, you have a receptor, and the experiments follow: binding assays, competition curves, functional readouts through a known G protein, receptor-expressing cell lines, selective antagonist controls
BPC-157 is being investigated for its potential to accelerate tissue repair, ease chronic inflammation, and enhance recovery in both musculoskeletal and gut-related conditions
Bonomi M, Vezzoli V, Krausz C, Guizzardi F, Vezzani S, Simoni M, Bassi I, Duminuco P, Di Iorgi N, Giavoli C, Pizzocaro A, Russo G, Moro M, Fatti L, Ferlin A, Mazzanti L, Zatelli MC, Cannavo S, Isidori AM, Pincelli AI, Prodam F, Mancini A, Limone P, Tanda ML, Gaudino R, Salerno M, Francesca P, Maghnie M, Maggi M, Persani L, on Central Hypogonadism (NICe group) (2018) Italian Network on Central Hypogonadism, Italian Network Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH)
A vendor unwilling to publish HPLC/MS results for the batch you're buying has nothing to verify their purity claim against
This does not affect reconstitution, but it means the mechanism of action differs
Cell 169 , 132147.e116 (2017)